First National Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+1,393
New +$209K 0.01% 361
2015
Q4
Sell
-2,691
Closed -$222K 307
2015
Q3
$222K Sell
2,691
-230
-8% -$20.5K 0.04% 265
2015
Q2
$258K Buy
2,921
+39
+1% +$3.58K 0.04% 251
2015
Q1
$255K Buy
2,882
+216
+8% +$19.2K 0.04% 238
2014
Q4
$221K Sell
2,666
-226
-8% -$18.7K 0.04% 228
2014
Q3
$244K Sell
2,892
-713
-20% -$57.7K 0.05% 226
2014
Q2
$293K Buy
+3,605
New +$284K 0.06% 212

Other funds holding NVS

First National Trust's NVS Position: Q2 2026 in Review

First National Trust opened a new position in Novartis (NVS) in Q2 2026: 1,393 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #361 among its holdings. This is a return to the name: First National Trust previously reported a position in NVS as recently as Q3 2015.

First National Trust first reported a position in NVS in Q2 2014 and has held it in 7 quarters since. The position peaked at $293K in Q2 2014. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • First National Trust held 1,393 shares of Novartis worth $218K as of Q2 2026.
  • Novartis was a new First National Trust position in Q2 2026.
  • Novartis made up 0.01% of First National Trust's portfolio in Q2 2026, its #361 holding.
  • First National Trust first reported a position in Novartis in Q2 2014 and has held it in 7 quarters since.
  • First National Trust's Novartis position peaked at $293K in Q2 2014.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on First National Trust's 13F filing for Q2 2026, filed 30 Jul 2026.